Emerging research has identified a potential biological connection between autism spectrum disorder and Alzheimer's disease, ...

An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a ...

Findings suggest that regular physical activity and adequate sleep may lower dementia risk, emphasizing the need for evidence-based lifestyle guidelines.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

The prevalence of invasive bacterial infection in young febrile infants is estimated at 1%–4%, with the highest rates in ...

A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...

Replimune received a second FDA complete response letter for RP1 in advanced melanoma, raising questions about the viability of its oncolytic immunotherapy program. Replimune Group received a complete ...

A woman in her 50s with genetically confirmed Huntington’s disease presented with right-sided arm sensory symptoms that evolved over days and persisted for at least 1 month. Neurological examination ...

APOE4 homozygosity increased risk for psychosis in Alzheimer disease, with women vs men showing higher odds for delusions and hallucinations.

This case report describes a woman in her 60s diagnosed with primary vitreoretinal lymphoma (PVRL) with leptomeningeal ...

Autism and Alzheimer’s disease have long occupied separate corners of neuroscience. One is diagnosed in childhood; the other ...

Unprecedented,” “remarkable” and “transformative” were just a few of the descriptives tossed out by Wall Street analysts in response to Revolution Medicines Inc.’s phase III readout, showing RAS ...